Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
May 08, 2026
Why the Amplify Digital Payments ETF (IPAY) Stands Out in a Digital-First World

Why the Amplify Digital Payments ETF (IPAY) Stands Out in a Digital-First World

Key Takeaways

  • Rising global e-commerce and smartphone penetration will fuel demand for digital payment solutions, positioning IPAY for structural growth.
  • AI integration in fraud prevention and personalized payments represents a major macro driver enhancing sector efficiency and adoption.
  • Regulatory clarity on stablecoins and open banking could accelerate cross-border transactions, benefiting IPAY's global holdings.
  • Recent fund outflows amid market volatility highlight short-term risks, but long-term fund flows may rebound with economic recovery.
  • Interest rate cuts expected in 2026 could boost consumer spending and buy-now-pay-later (BNPL) services within the ETF's portfolio.
  • Top holdings like Visa (V) and Mastercard (MA) offer resilient exposure to card networks amid shifting payment rails.

Understanding IPAY's Portfolio and Strategy

The Amplify Digital Payments ETF (IPAY) tracks the Nasdaq CTA Global Digital Payments Index, focusing on companies that generate significant revenue from digital payments—think card networks, processors, infrastructure providers, mobile wallets, and BNPL services. With an expense ratio of 0.75% and about $174 million in assets under management (AUM), it holds around 40 stocks in a non-diversified setup, using market-cap weighting to stay true to its theme.

Its top holdings make up over 54% of assets: Visa (V) at 5.81%, Affirm Holdings at 5.74%, Block (SQ) at 5.74%, Mastercard (MA) at 5.52%, and Adyen NV at 5.49%. The portfolio leans heavily into transaction and payment processing services (78%), with consumer finance at 12%, giving it a concentrated play on fintech innovation. Geographically, it's 79% U.S.-focused, with notable spots in the Netherlands (5.5%) and U.K. (5.4%).

From what I see, this setup capitalizes on the ongoing shift from cash to digital transactions, powered by e-commerce growth and mobile adoption. IPAY's performance will depend on how well its holdings capture increasing transaction volumes, which ties it closely to global consumer trends and innovations in payments infrastructure.

Key Catalysts Driving IPAY Forward

Looking ahead to 2026, several factors could influence IPAY's path. Real-time payments and ISO 20022 standards are gaining traction, which should improve efficiency for processors like PayPal (PYPL) and Block (SQ), cutting settlement times and lifting volumes. Regulatory progress is another big one: U.S. stablecoin bills like the GENIUS Act and the EU's PSD3 could provide clearer rules for digital assets, helping holdings such as Coinbase (COIN).

Economic resilience amid trade tensions should support consumer spending and BNPL expansion—expected to hit $911 billion by 2030—benefiting names like Affirm. Quarterly index rebalancing might bring in new players in tokenization and AI-driven payments. Fund flows have been negative lately at -$4.32 million over the past month, but they could turn positive with improving sector sentiment and Fed cuts to around 3.125%. I also checked this using Tickeron’s AI Screener to gauge how IPAY stacks up against peers. Overall, these elements point to meaningful upside from the evolving payments landscape.

Sector and Macro Outlook for Digital Payments

The digital payments sector, which backs IPAY's Nasdaq CTA Global Digital Payments Index, is set for strong growth to $712 billion by 2033 at a 21.8% CAGR, driven by smartphone growth and e-commerce. Macro supports like easing inflation and Fed rate cuts should increase transaction volumes for dominant card networks like Visa (V) and Mastercard (MA).

That said, the sector remains sensitive to interest rates—prolonged higher rates could squeeze BNPL providers through higher borrowing costs, while cuts improve affordability. Global growth holds up cross-border activity, though trade risks linger for international holdings. Broader equity trends favoring tech and fintech, plus blockchain for quicker settlements, fit the index well. Currency swings could affect the 21% non-U.S. exposure, but stabilizing rates and AI in fraud prevention strengthen the outlook. One thing that stands out is how these dynamics reinforce IPAY's positioning.

Insights from Tickeron’s Trend Prediction Engine

In my research, I’ve relied on Tickeron’s Trend Prediction Engine, an AI tool that forecasts whether assets like ETFs—including IPAY—might trend bullish, bearish, or sideways over the next week or month. It sifts through massive datasets to detect trends, potential breakouts or reversals, and covers thousands of instruments with searchable predictions, historical patterns, and alerts for high-probability signals. I find it particularly useful for short-term trades and confirming longer trends in volatile markets. If you’re analyzing ETFs like IPAY, it’s worth exploring to add data-driven clarity to your process.

IPAY's Long-Term Potential and Structural Shifts

IPAY's strongest case lies in long-term payments trends, with the global mobile payments market projected at $27.81 trillion by 2032 and a 28.1% CAGR, thanks to e-commerce, smartphones, and contactless payments. Advances in AI for personalization and fraud detection, blockchain settlements, and tokenization will benefit the ETF's infrastructure leaders.

Demographics play a role too—millennials and Gen Z favor digital wallets—aligning with economic cycles and rate normalization. Fintech investment flows, regulatory sandboxes, and open finance broaden the index's opportunities. Key holdings like American Express (AXP) and Capital One (COF) should gain from embedded finance and stablecoins. I’m watching this closely, as IPAY's thematic focus aligns it well with these multi-year shifts, even as competition from disruptors bears monitoring.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: IPAY

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


IPAY in downward trend: price dove below 50-day moving average on September 08, 2026

IPAY moved below its 50-day moving average on September 08, 2026 date and that indicates a change from an upward trend to a downward trend. In 34 of 38 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IPAY as a result. In 66 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 79%.

The Moving Average Convergence Divergence Histogram (MACD) for IPAY turned negative on August 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 40 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.

The 10-day moving average for IPAY crossed bearishly below the 50-day moving average on September 15, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IPAY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

The Aroon Indicator for IPAY entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where IPAY's RSI Indicator exited the oversold zone, 32 of 38 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 53 of 68 cases where IPAY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.

Following a +2.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where IPAY advanced for three days, in 257 of 320 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

IPAY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Notable companies

The most notable companies in this group are VISA (NYSE:V), Mastercard (NYSE:MA), American Express Company (NYSE:AXP), Capital One Financial (NYSE:COF), PayPal Holdings (NASDAQ:PYPL), Block Inc (NYSE:XYZ), StoneCo Ltd (NASDAQ:STNE).

Industry description

The investment seeks investment results that generally correlate (before fees and expenses) to the total return performance of the Nasdaq CTA Global Digital Payments Index. The index tracks the performance of common stocks (or corresponding American Depositary Receipts (“ADRs”) or Global Depositary Receipts (“GDRs”)) of Mobile Payments Companies. Under normal circumstances, the fund invests at least 80% of its net assets (plus borrowings for investment purposes) in Mobile Payments Companies. The fund is non-diversified.

Market Cap

The average market capitalization across the Amplify Digital Payments ETF (IPAY) ETF is 63.88B. The market cap for tickers in the group ranges from 930.67M to 690.38B. V holds the highest valuation in this group at 690.38B. The lowest valued company is IBTA at 930.67M.

High and low price notable news

The average weekly price growth across all stocks in the Amplify Digital Payments ETF (IPAY) ETF was 26%. For the same ETF, the average monthly price growth was 17%, and the average quarterly price growth was 72%. STNE experienced the highest price growth at 24%, while GPN experienced the biggest fall at -3%.

Volume

The average weekly volume growth across all stocks in the Amplify Digital Payments ETF (IPAY) ETF was 45%. For the same stocks of the ETF, the average monthly volume growth was 80% and the average quarterly volume growth was 4%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 60
P/E Growth Rating: 59
Price Growth Rating: 59
SMR Rating: 52
Profit Risk Rating: 87
Seasonality Score: -6 (-100 ... +100)
View a ticker or compare two or three
IPAY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category MiscellaneousSector

Category
Miscellaneous Sector
Address
Amplify ETF Trust3250 Lacey Road, Suite 130Downers Grove
Phone
(630) 464-7600
Web
N/A
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.